References
- Fu Lx. M., Hoebeke J., Matsui A., et al. Autoantibodies against cardiac G-protein coupled receptors defined different populations with cardiomyopathies but not with hypertension. Clin. Immunol. Immunopathol. 1994; 72: 15–20
- Matsui S., Fu Lx. M., Shimizu M., et al. Dilated cardiomyopathy defines serum autoantibodies against G-coupled cardiovascular receptors. Autoimmunity 1995; 21: 85–88
- Limas C. J., Goldenberg I. F., Limas C. Autoantibodies against β-adrenoceptors in human idiopathic dilated cardiomyopathy. Circ. Res. 1989; 64: 97–103
- Fu Lx. M., Magnusson Y., Bergh C., et al. Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardio myopathy. J. Clin. Invest. 1993; 91: 1964–1968
- Wallukat G., Fu Lx. M., Magnusson Y., et al. Agonistic effects of anti-peplide antibodies and autoantibodies directed against adrenergic and cholinergic receptors: absence of desensitization. Blood Pressure 1996; 5(Suppl. 3)31–36
- Zhao R.-R., Wang W. Z., Wu B.-W., et al. Effects of anti-peptide antibodies against the second extracellular loop of human M2-muscarinic acetylcholine receptors on transmembrane potentials and currents in guinea pig ventricular myocytes. Mol. Cell Biochem. 1996; 163/164: 185–193
- Wang W. Z., Zhao R.-R., Wu B.-W., et al. Effects of antipeptide antibodies against human M2-muscarinic receptors on cardiac function in rats in vivo. Blood Pressure 1996; 5(Suppl. 3)25–27
- Cohen I. K., Cooke A. Natural autoantibodies might prevent autoimmune diseases. Immunology Today 1986; 12: 363
- Kong H. Y. Modern Autoimmunologie Diseases. PRA Medicine Press, Beijing 1996; 1–29
- Brandenbury R. O., Chazov E., Cherian G., et al. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathy. Br. Heart J. 1980; 44: 672–673
- Xiao L. Y., Wang D. R., Mu J. W. Preparation of monoclonal anti-HBL antibodies and their application for epitope mapping of HBL. Chin. J. Microbiol. 1993; 13(5)277–280
- Porstmann T., Kiessig S. T. Enzyme immunoassay techniques-an overview. J. Immunol. Mel. 1992; 150: 5–21
- Zar J. I.I. Biostatistical Analysis. 2nd ed. Prentice-Hall, Inc., Englewood Cliffing 1984; 95–96
- Magnusson Y., Marullo S., Hoyer S., et al. Mapping of a functional autoimmune epitope on the β1-adrenoceptor in patients with idiopathic dilated cardiomyopathy. J. Clin. Invest. 1990; 86: 1658–1663
- Wallukat G., Morwinski R., Magnusson Y., Hoebeke J., Wollenberger A. Autoantibodies against the β1 adrenoceptor in myocarditis and dilated cardiomyopathy: localization of two epitopes. Z. Kardiol. 1992; 81(Suppl. 4)79–83
- Wallukat G., Wollenberger A., Morwinski R., Pitschner H.-F. Anti-β1-adrenoceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: mapping of epitopes in the first and second extracellular loops. J. Mol. Cell Cardiol. 1995; 27: 397–406
- Walford A. L. The immunologic theory of aging, current status. Ted. Proc. 1974; 33: 2020
- Effors R. B. Stress, Immunity and Aging. Marcel Dekker, New York 1984
- Hirokwa T. The thymus and aging. Immunology and Aging, T. Makinodan, E. Yunis. Plenum Medical Book Company, New York 1977; 51–72
- Markus H. S., Hoghill P. J. Impaired splenic function in elderly people. Age and aging 1991; 20(4)287